Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
BioStem Technologies
(OTCPK:BSEM)
Intraday
$9.355
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$9.355
0
[0.00%]
At close: Apr 24
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for BioStem Technologies Stock (OTC:BSEM)
BioStem Technologies Stock (OTC: BSEM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, September 11, 2023
NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova Allograft
Benzinga Newsdesk
-
Sep 11, 2023, 8:05AM
Monday, January 30, 2023
How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond
Gita Karunakaran
-
Sponsored
Monday, January 23, 2023
BioStem Reveals Plans For New Products, Expanded Sales And Manufacturing Capabilities At Dawson James Small Cap Growth Conference
Rachael Green
-
Sponsored
Tuesday, January 17, 2023
Benzinga Speaks To BioStem Technologies About How Its Technology Is Changing The World Of Wound Care
Faith Ashmore
-
Sponsored
Friday, January 13, 2023
2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion
Gita Karunakaran
-
Sponsored
Monday, November 07, 2022
Zacks Investment Research Initiates Coverage On BioStem Technologies With a Valuation of $6.40
Benzinga Newsdesk
-
Nov 7, 2022, 1:05PM
Thursday, September 22, 2022
BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
Zacks Small Cap Research
-
Sep 22, 2022, 4:50PM
Friday, September 09, 2022
BioStem Technologies, Inc. Second Quarter Financial Results Call, August 22, 2022
BioStem Technologies
-
Sep 9, 2022, 1:23PM
Thursday, September 08, 2022
BioStem Technologies Reports 133% Year-Over-Year Revenue Growth As It Expands Distribution of Patented Allograft Tech
Rachael Green
-
Sponsored
Thursday, June 23, 2022
BioStem Technologies' Local MicroEnvironment Activation Possible Key To Reversing And Repairing Diseases-Caused Tissue Damage
Jacinta Sherris
-
Jun 23, 2022, 9:07AM
Friday, June 17, 2022
Benzinga Announces This Week's All Access Guests
Kenneth Adams
-
Jun 17, 2022, 8:39AM
Monday, May 16, 2022
EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY
Michael Cohen
-
May 16, 2022, 9:31AM
Thursday, April 22, 2021
Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness
Jelena Martinovic
-
Apr 22, 2021, 11:27AM
